Effectiveness of the combination of a whole‐blood interferon‐gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy
Effectiveness of the combination of a whole‐blood interferon‐gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Effectiveness of the combination of a whole‐blood interferon‐gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy have?
Effectiveness of the combination of a whole‐blood interferon‐gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy has 100 citations in the OpenAlex counts ScholarIQ stores.
When was Effectiveness of the combination of a whole‐blood interferon‐gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy published?
Effectiveness of the combination of a whole‐blood interferon‐gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy has 2008 year in the ScholarIQ index.
What is the open-access status of Effectiveness of the combination of a whole‐blood interferon‐gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy?
Effectiveness of the combination of a whole‐blood interferon‐gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy has closed oa status in the ScholarIQ index.
What is the DOI of Effectiveness of the combination of a whole‐blood interferon‐gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy?
The DOI for Effectiveness of the combination of a whole‐blood interferon‐gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy is on the source record.
What is the PMID of Effectiveness of the combination of a whole‐blood interferon‐gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy?
The PMID for Effectiveness of the combination of a whole‐blood interferon‐gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy is on the source record.
What is the OpenAlex record for Effectiveness of the combination of a whole‐blood interferon‐gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy?
The OpenAlex for Effectiveness of the combination of a whole‐blood interferon‐gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy is on the source record.